h.hartmann
Submits third-party assay reports on material purchased directly. Based in Nairobi.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.09%
n=9
Suppliers covered
7
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041776 | SS-31 (Elamipretide) | FGP | FGP-2601-R1916 | Medutest | 2026-Q2 | 99.93 | 3.97 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043356 | BPC-157 | CPC | CPC-2510-R2456 | PeptideMeter | 2026-Q1 | 98.59 | 8.90 | 107.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042572 | BPC-157 | ERP | ERP-2509-G8440 | Kestrel | 2026-Q1 | 99.09 | 3.06 | 90.1 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-018919 | Semaglutide | FGP | FGP-2506-J9812 | Kestrel | 2025-Q4 | 99.93 | 4.92 | 94.7 | Supplier-supplied | 0 | PASS |
| AX-2025-018959 | PT-141 (Bremelanotide) | FGP | FGP-2505-K1249 | VendorInvestigate | 2025-Q4 | 99.26 | 3.17 | 92.3 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019238 | BPC-157 | TFC | TFC-2507-J6580 | PeptideMeter | 2025-Q3 | 99.37 | 4.08 | 103.3 | Supplier-supplied | 3 | FAIL |
| AX-2024-005548 | Tirzepatide | QST | QST-2409-K8302 | Janoshik | 2024-Q4 | 98.26 | 6.11 | 95.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005211 | Semax | SSA | SSA-2410-G6381 | VendorInvestigate | 2024-Q4 | 98.38 | 10.02 | 95.9 | Buyer-sourced | 1 | FAIL |
| AX-2024-005075 | Semaglutide | MKM | MKM-2403-C3618 | Nordanalyt | 2024-Q2 | 98.32 | 6.39 | — | Supplier-supplied | 1 | MARGINAL |